基于正虚毒泛病机探讨肿瘤外泌体与肺癌发生发展的关系
Exploring the Relationship between Tumor Exosomes and Lung Cancer Development Based on the Pathogenesis of Positive Deficiency and Toxicity Flooding
DOI: 10.12677/acm.2024.14112908, PDF,   
作者: 李丰池:黑龙江中医药大学第一临床医学院,黑龙江 哈尔滨;隋博文*:黑龙江中医药大学附属第一医院肿瘤一科,黑龙江 哈尔滨
关键词: 正虚毒泛肺癌外泌体Positive Deficiency and Toxicity Flooding Lung Cancer Exosomes
摘要: 肺癌是我国发病率和死亡率最高的癌症之一,主要症状为长期咳嗽、咯血和肺部阴影。每年约有63.1万人死于肺癌,主要危险因素包括吸烟、空气污染等。肺癌的发展涉及肿瘤细胞与微环境的复杂互动,其中包括外泌体,这些细胞囊泡在肿瘤生长和侵袭中扮演重要角色,并可能成为治疗靶点。中医认为肺癌由正气亏虚、阴阳失调引起,病性虚实夹杂,治疗需结合宣肺理气、化痰祛瘀、益气健脾、温阳补肾等多种方法。肺癌的治疗既要扶正又要祛邪,针对“痰”“瘀”“毒”等病理特点进行综合治疗。充分发挥中医药扶正祛邪,控制肿瘤发展的作用。
Abstract: Lung cancer is one of the cancers with the highest morbidity and mortality in China, and the main symptoms are prolonged cough, hemoptysis and lung shadows. About 631,000 people die of lung cancer every year, and the main risk factors include smoking and air pollution. Lung cancer development involves complex interactions between tumor cells and the microenvironment, including exosomes, which are cellular vesicles that play an important role in tumor growth and invasion and may be therapeutic targets. According to TCM, lung cancer is caused by deficiency of positive energy and imbalance of yin and yang, and the disease is characterized by a mixture of deficiency and reality, so the treatment needs to combine various methods, such as declaring the lung and regulating the qi, resolving phlegm and eliminating blood stasis, benefiting qi and strengthening the spleen, warming the yang and nourishing the kidneys. The treatment of lung cancer should not only support the positive but also dispel the evil, and carry out comprehensive treatment according to the pathological characteristics of “phlegm”, “blood stasis”, “poison” and so on. It should give full play to the role of Chinese medicine in supporting the positive and dispelling the evil, and controlling the development of tumor.
文章引用:李丰池, 隋博文. 基于正虚毒泛病机探讨肿瘤外泌体与肺癌发生发展的关系[J]. 临床医学进展, 2024, 14(11): 505-510. https://doi.org/10.12677/acm.2024.14112908

参考文献

[1] Wu, F., Wang, L. and Zhou, C. (2020) Lung Cancer in China: Current and Prospect. Current Opinion in Oncology, 33, 40-46. [Google Scholar] [CrossRef] [PubMed]
[2] Whiteside, T.L. (2008) The Tumor Microenvironment and Its Role in Promoting Tumor Growth. Oncogene, 27, 5904-5912. [Google Scholar] [CrossRef] [PubMed]
[3] Naureen, J. and Debabrata, M. (2017) Exosomes and Their Role in the Micro-/Macro-Environment: A Comprehensive Review. The Journal of Biomedical Research, 31, 386-394. [Google Scholar] [CrossRef] [PubMed]
[4] Whiteside, T.L. (2017) The Effect of Tumor-Derived Exosomes on Immune Regulation and Cancer Immunotherapy. Future Oncology, 13, 2583-2592. [Google Scholar] [CrossRef] [PubMed]
[5] 王丽, 顾岩. 外泌体在肺癌诊断及治疗中的应用前景[J]. 临床肺科杂志, 2021, 26(1): 141-146.
[6] 林丽珠, 王思愚, 黄学武. 肺癌中西医结合诊疗专家共识[J]. 中医肿瘤学杂志, 2021, 3(6): 1-17.
[7] Mu, C., Zhang, X., Wang, L., Xu, A., Ahmed, K.A., Pang, X., et al. (2017) Enhanced Suppression of Polyclonal CD8+25+ Regulatory T Cells via Exosomal Arming of Antigen-Specific Peptide/MHC Complexes. Journal of Leukocyte Biology, 101, 1221-1231. [Google Scholar] [CrossRef] [PubMed]
[8] Ning, Y., Shen, K., Wu, Q., Sun, X., Bai, Y., Xie, Y., et al. (2018) Tumor Exosomes Block Dendritic Cells Maturation to Decrease the T Cell Immune Response. Immunology Letters, 199, 36-43. [Google Scholar] [CrossRef] [PubMed]
[9] Salimu, J., Webber, J., Gurney, M., Al‐Taei, S., Clayton, A. and Tabi, Z. (2017) Dominant Immunosuppression of Dendritic Cell Function by Prostate‐Cancer‐Derived Exosomes. Journal of Extracellular Vesicles, 6, Article 1368823. [Google Scholar] [CrossRef] [PubMed]
[10] Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., et al. (2012) MicroRNAs Bind to Toll-Like Receptors to Induce Prometastatic Inflammatory Response. Proceedings of the National Academy of Sciences, 109, E2110-E2116. [Google Scholar] [CrossRef] [PubMed]
[11] Hong, C.S., Muller, L., Boyiadzis, M. and Whiteside, T.L. (2014) Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia. PLOS ONE, 9, e103310. [Google Scholar] [CrossRef] [PubMed]
[12] 熊文杰, 刘焕勋, 史敦云, 等. 骨髓瘤细胞来源外泌体对NK细胞表面活化受体的影响[J]. 中国实验血液学杂志, 2017, 25(6): 1713-1717.
[13] 尹春来, 赵雪梅, 侯召华, 等. 外泌体在肿瘤免疫逃逸和耐受中的作用[J]. 生物化学与生物物理进展, 2019, 46(5): 433-440.
[14] 王郅宜, 高磊, 胡少朴, 等. 从正邪理论探讨肿瘤免疫微环境及中医辨治思路[J]. 现代中医临床, 2023, 30(6): 71-75.
[15] Zhong, Q., Shi, Z., Zhang, L., Zhong, R., Xia, Z., Wang, J., et al. (2017) The Potential of Epimedium koreanum Nakai for Herb-Drug Interaction. Journal of Pharmacy and Pharmacology, 69, 1398-1408. [Google Scholar] [CrossRef] [PubMed]
[16] 孙凯廷, 蔡美, 曾梅艳. 益肺饮联合CIK细胞对肺癌A549细胞免疫逃逸干预的研究[J]. 湖南中医药大学学报, 2019, 39(9): 1084-1088.
[17] Whiteside, T.L. (2016) Exosomes and Tumor-Mediated Immune Suppression. Journal of Clinical Investigation, 126, 1216-1223. [Google Scholar] [CrossRef] [PubMed]
[18] Kahlert, C. and Kalluri, R. (2013) Exosomes in Tumor Microenvironment Influence Cancer Progression and Metastasis. Journal of Molecular Medicine, 91, 431-437. [Google Scholar] [CrossRef] [PubMed]